Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DPS4 | ISIN: SE0008613731 | Ticker-Symbol: 9II
Frankfurt
27.06.25 | 08:07
0,044 Euro
+19,78 % +0,007
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOVICA INTERNATIONAL AB Chart 1 Jahr
5-Tage-Chart
BIOVICA INTERNATIONAL AB 5-Tage-Chart

Aktuelle News zur BIOVICA INTERNATIONAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBiovica International AB - Annual Report for the Financial Year 2024/2025 Published212UPPSALA, SE / ACCESS Newswire / June 27, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Annual Report for the finacial year 2024/2025 for Biovica International AB is published...
► Artikel lesen
DoBiovica International: Biovica Granted New European Patent175UPPSALA, SE / ACCESS Newswire / June 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica today announced that the European Patent Office (EPO) has granted a new patent for...
► Artikel lesen
18.06.Biovica International: Year-End Report 2024/2025212UPPSALA, SE / ACCESS Newswire / June 18, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Positive development in the USA continuesSEK tQ424/25Q423/24May-April 24/25May-April 23/24Net...
► Artikel lesen
11.06.Biovica International: Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company216UPPSALA, SE / ACCESS Newswire / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agreement...
► Artikel lesen
11.06.Notice of Extra General Meeting in Biovica International AB241UPPSALA, SE / ACCESS Newswire / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The shareholders of Biovica International AB, reg. no. 556774-6150 (the "Company"), are...
► Artikel lesen
BIOVICA INTERNATIONAL Aktie jetzt für 0€ handeln
11.06.Biovica International: Biovica Resolves on a Fully Guaranteed Rights Issue of Approximately SEK 80 million at SEK 0.63 Per Share203NOT TO BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA...
► Artikel lesen
10.06.Biovica International: Biovica Announces Financial Targets Following Key Partnerships and Commercial Progress251UPPSALA, SE / ACCESS Newswire / June 10, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces financial goals for...
► Artikel lesen
10.06.Biovica International: Biovica Secures Three New Work Orders in Pharma Services of 2,5 MSEK in Value182UPPSALA, SE / ACCESS Newswire / June 10, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, has signed three new work orders within...
► Artikel lesen
23.05.Biovica International: New DiviTum TKa Data to be Presented at ASCO in Three Cancer Types260UPPSALA, SE / ACCESS Newswire / May 23, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in cancer monitoring, today announces that three abstracts based on studies...
► Artikel lesen
19.05.Biovica International: Biovica Signs Major Service Agreement and First Study Work Order of 4 MSEK229UPPSALA, SE / ACCESS Newswire / May 19, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces the signing of a Master...
► Artikel lesen
13.05.Biovica International: Biovica Collaborates with Tempus to Expand the Commercial Reach of DiviTum TKa392UPPSALA, SE / ACCESS Newswire / May 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, has entered a reference lab agreement...
► Artikel lesen
26.03.Biovica International: DiviTum TKa Data in Combination with Inflammation Proteins Presented at the AACR Meeting Enhance Precision to Predict Efficacy of Immunotherapy361UPPSALA, SE / ACCESS Newswire / March 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, a leader in blood-based biomarker assays in oncology, today announces that an abstract...
► Artikel lesen
13.03.Biovica International AB receives observation status121Today, March 13, 2025, Biovica International AB (the "Company") disclosed its financial report for the period November 2024 - January 2025 with information on the Company's financial situation. The...
► Artikel lesen
13.03.Biovica International: Biovica Q3 Interim report Nov 2024 - Jan 2025297UPPSALA, SE / ACCESS Newswire / March 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Quarterly sales doubled, expanding market potential exponentiallySEK tQ3 24/25Q3 23/24May-Jan...
► Artikel lesen
12.03.Biovica International: Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment322UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader in blood-based cancer monitoring, announces a partnership with...
► Artikel lesen
10.03.Biovica International: Biovica Signs New Work Order with US Biotech Company for TKa Testing Services250UPPSALA, SE / ACCESS Newswire / March 10, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has secured a new work order (WO) valued...
► Artikel lesen
05.03.Biovica International: Biovica Signs Agreement With Eurobio Scientific Covering 60 Percent of European Market402UPPSALA, SE / ACCESS Newswire / March 5, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, has signed a collaboration agreement with Eurobio Scientific...
► Artikel lesen
06.02.Biovica International: Board Member of Biovica Resigns at Own Request283UPPSALA, SE / ACCESS Newswire / February 6, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica today announces that board member Ulf Jungnelius has resigned from the board at...
► Artikel lesen
06.02.Nomination Committee for Biovica International AB for the 2025 Annual General Meeting268UPPSALA, SE / ACCESS Newswire / February 6, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The Nomination Committee prior to the 2025 Annual General Meeting will consist of three...
► Artikel lesen
13.01.Biovica International: Biovica Secures Major Work Order for TKa Testing Services273UPPSALA, SE / ACCESSWIRE / January 13, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has signed an order with a total value of...
► Artikel lesen
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1